Overview

The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether short term treatment with a antihypertensive medication prazosin, can influence the levels of a dopamine in the brain. We will examine the levels of dopamine in the the brain using Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI). We hypothesize that there will be no significant changes in dopamine levels in healthy individuals taking prazosin.
Phase:
Phase 1
Details
Lead Sponsor:
Centre for Addiction and Mental Health
Collaborators:
Ontario Lung Association
Pfizer
Treatments:
Dopamine
Dopamine Agents
Prazosin